Design, synthesis, and pharmacological evaluation of azetedine and pyrrolidine derivatives as dual norepinephrine reuptake inhibitors and 5-HT1A partial agonists

被引:14
|
作者
Pettersson, Martin [1 ]
Campbell, Brian M. [1 ]
Dounay, Amy B. [1 ]
Gray, David L. [1 ]
Xie, Longfei [1 ]
O'Donnell, Christopher J. [1 ]
Stratman, Nancy C. [1 ]
Zoski, Kim [1 ]
Drummond, Elena [1 ]
Bora, Gary [1 ]
Probert, Al [1 ]
Whisman, Tammy [1 ]
机构
[1] Pfizer Global Res & Dev, Groton, CT 06340 USA
关键词
Norepinephrine reuptake inhibitor; 5-HT1A agonist; NRI; NET; DAT; SERT; ADHD; Depression; EFFICACY; REBOXETINE;
D O I
10.1016/j.bmcl.2010.11.066
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Compounds with combined norepinephrine reuptake inhibitor (NRI) and serotonin 1A (5-HT1A) partial agonist pharmacology may offer a new therapeutic approach for treating symptoms of neuropsychiatric disorders including ADHD, depression, and anxiety. Herein we describe the design and optimization of novel chemical matter that exhibits favorable dual NRI and 5-HT1A partial agonist activity. Lead compounds in this series were found to be devoid of activity at the dopamine transporter and were shown to be brain penetrant with high receptor occupancy. (C) 2010 Elsevier Ltd. All rights reserved.
引用
收藏
页码:865 / 868
页数:4
相关论文
共 50 条
  • [21] Design, Synthesis and 5-HT/NE Dual Reuptake Inhibition Activity of Phenylbenzamidine Derivatives
    Qin Fang
    Yang Jing
    Wen Hui
    Zhang Jian-Jun
    Wang Ya-Fang
    Ji Cheng-Xue
    Yang Guang-Zhong
    CHEMICAL JOURNAL OF CHINESE UNIVERSITIES-CHINESE, 2009, 30 (05): : 938 - 944
  • [22] Neurochemical evaluation of the novel 5-HT1A receptor partial agonist/serotonin reuptake inhibitor, vilazodone
    Hughes, ZA
    Staff, KR
    Langmead, CJ
    Hill, M
    Bartoszyk, GD
    Hagan, JJ
    Middlemiss, DN
    Dawson, LA
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2005, 510 (1-2) : 49 - 57
  • [23] Synthesis and pharmacological evaluation of benzamide derivatives as selective 5-HT4 receptor agonists
    Sonda, S
    Kawahara, T
    Katayama, K
    Sato, N
    Asano, K
    BIOORGANIC & MEDICINAL CHEMISTRY, 2005, 13 (09) : 3295 - 3308
  • [24] Design and Synthesis of Piperazinylpyridine Derivatives as Novel 5-HT1A Agonists/5-HT3 Antagonists for the Treatment of Irritable Bowel Syndrome (IBS)
    Asagarasu, Akira
    Matsui, Teruaki
    Hayashi, Hiroyuki
    Tamaoki, Satoru
    Yamauchi, Yukinao
    Sato, Michitaka
    CHEMICAL & PHARMACEUTICAL BULLETIN, 2009, 57 (01) : 34 - 42
  • [25] Design and synthesis of reboxetine analogs morpholine derivatives as selective norepinephrine reuptake inhibitors
    Xu, Wenjian
    Gray, David L.
    Glase, Shelly A.
    Barta, Nancy S.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2008, 18 (20) : 5550 - 5553
  • [26] 5-HT1A agonists and dyskinesia in Parkinson's disease: a pharmacological perspective
    Huot, Philippe
    NEURODEGENERATIVE DISEASE MANAGEMENT, 2018, 8 (04) : 207 - 209
  • [27] Synthesis and evaluation of 4-(benzothiophenyl)piperidines and 4-(benzofuryl)piperidines as dual 5-HT1A receptor anatagonist/serotonin reuptake inhibitors.
    Spinazze, PG
    Rocco, VP
    He, JX
    Koch, DJ
    Kohn, TJ
    Honigschmidt, NA
    Takeuchi, K
    Ahmad, LJ
    Shaw, JL
    Threlkeld, PG
    Wainscott, DB
    Nelson, DLG
    Wong, DT
    Luecke, SH
    Godfrey, AG
    Hansen, MM
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2002, 224 : U52 - U52
  • [28] Design, synthesis, and biological evaluation of aralkyl piperazine and piperidine derivatives targeting SSRI/5-HT1A/5-HT7
    Wu, Jianwei
    Zhang, Zixue
    Zhang, Qingwei
    Li, Jianqi
    BIOORGANIC & MEDICINAL CHEMISTRY, 2024, 104
  • [29] A convenient synthesis by microwave heating and pharmacological evaluation of novel benzoyltriazole and saccharine derivatives as 5-HT1A receptor ligands
    Caliendo, G
    Fiorino, F
    Perissutti, E
    Severino, B
    Scolaro, D
    Gessi, S
    Cattabriga, E
    Borea, PA
    Santagada, V
    EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2002, 16 (1-2) : 15 - 28
  • [30] In Vitro Characterization of Vilazodone as a Dual-Acting Serotonin Reuptake Inhibitor and 5-HT1A Receptor Partial Agonist
    Kehne, John H.
    Bartoszyk, Gerd D.
    Greiner, Hartmut E.
    Pierz, Kerri A.
    Renda, Matthew J.
    van Amsterdam, Christoph
    Reed, Carol R.
    Athanasiou, Maria C.
    BIOLOGICAL PSYCHIATRY, 2010, 67 (09) : 237S - 237S